A commentary discusses the implications of successive negative trials for future telemonitoring research. It notes that future strategies must facilitate patients’ adherence to regular data transmission, and the emerging concept of “treatment burden” is helpful in understanding low adherence, which may result from patient perceptions that telemonitoring does not sufficiently improve the outcomes they value most to justify their efforts.